Literature DB >> 34976482

Large Pleural Effusion Secondary to Primary Signet-Ring Cell Adenocarcinoma of the Lung.

Sarah Baroud1, Sara Moustafa1, Halah Ibrahim1.   

Abstract

Primary signet-ring cell adenocarcinomas (SRCA) that occur outside the gastrointestinal tract are rare with few cases reported in the literature. They carry a poor prognosis and can be a challenge to diagnose. In this case report, we present the case of a 69-year-old female who presented to our hospital with a large left-sided pleural effusion. The findings seen on histopathology and immunohistochemistry (IHC) staining of the pleural fluid were consistent with primary signet-ring cell adenocarcinoma of the lung, and further investigations excluded a secondary source of malignancy. To the best of our knowledge, this is the first reported case of pleural effusion without an underlying lung mass diagnosed as primary signet-ring cell adenocarcinoma of the lung. Given how rare primary signet-ring cell adenocarcinoma of the lung is, it is important for physicians to carry out a comprehensive diagnostic workup to differentiate between primary and metastatic signet-ring cell adenocarcinoma as this will determine prognosis and treatment.
Copyright © 2021, Baroud et al.

Entities:  

Keywords:  histopathology (hp); immunohistochemistry staining; left-sided pleural effusion; primary signet ring cell adenocarcinoma of the lung; signet ring cell adenocarcinoma

Year:  2021        PMID: 34976482      PMCID: PMC8712097          DOI: 10.7759/cureus.19846

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  7 in total

1.  Primary signet-ring cell carcinoma of the lung: a case report with an immunohistochemical study.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

2.  Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas.

Authors:  S H Merchant; M B Amin; P Tamboli; J Ro; N G Ordóñez; A G Ayala; B A Czerniak; J Y Ro
Journal:  Am J Surg Pathol       Date:  2001-12       Impact factor: 6.394

3.  Primary signet ring cell adenocarcinomas of the lung: a clinicopathological study of 15 cases.

Authors:  C Y Castro; C A Moran; D G Flieder; S Suster
Journal:  Histopathology       Date:  2001-10       Impact factor: 5.087

4.  BRAF inhibitors in metastatic non-small cell lung cancer.

Authors:  Geòrgia Anguera; Margarita Majem
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

5.  Primary signet-ring cell carcinoma of the lung treated with crizotinib: A case report.

Authors:  Yue-Qin Hao; Hua-Ping Tang; Hong-Yun Liu
Journal:  Oncol Lett       Date:  2015-03-02       Impact factor: 2.967

6.  Primary signet-ring adenocarcinoma of the lung: A rare lung tumor.

Authors:  Varun Rajpal; Rahul Kumar Sharma; Charul Dabral; Deepak Talwar
Journal:  South Asian J Cancer       Date:  2019 Oct-Dec

7.  Signet-ring cell adenocarcinoma of unknown primary presenting with superior vena cava (SVC) syndrome: rare type of cancer.

Authors:  Ramon Bagaporo Larrazabal; Paula Victoria Catherine Cheng; Aileen David-Wang; Daryl Requiso
Journal:  BMJ Case Rep       Date:  2019-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.